Atomo Diagnostics Ltd (AT1)

Currency in AUD
0.02
0.00(0.00%)
Closed·
Trading near 52-week Low
AT1 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.020.02
52 wk Range
0.020.05
Key Statistics
Bid/Ask
0.02 / 0.02
Prev. Close
0.02
Open
0.02
Day's Range
0.02-0.02
52 wk Range
0.02-0.05
Volume
2.17M
Average Volume (3m)
1.31M
1-Year Change
-10.5263%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
AT1 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Liquid assets exceed short term obligations

Atomo Diagnostics Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell

Atomo Diagnostics Ltd Earnings Call Summary for Q4/2026

  • Atomo Diagnostics reported FY 2026 revenue of AUD 5.3M, up 40% YoY, with Q4 revenue reaching AUD 2.3M driven by HIV testing and OEM sales.
  • Company ended period with AUD 3.7M cash, zero debt, and AUD 1.5M in unfulfilled orders expected to convert in FY 2027, supporting near-term momentum.
  • Management targeting breakeven with new Gen 2 blister machine in Sydney expected operational by end of 2026 to improve margins and reduce COGS.
  • Shares unchanged at $0.02, near 52-week low, as investors await profitability; no dividend planned until breakeven achieved per board guidance.
  • Growth strategy focuses on HIV self-testing expansion in ANZ, European partnerships, active syphilis test launch, and liver function test development.
Last Updated: 2026-07-23, 09:36 p/m
Read Full Transcript

Earnings

Latest Release
Apr 29, 2026
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

AT1 Income Statement

Compare AT1 to Peers and Sector

Metrics to compare
AT1
Peers
Sector
Relationship
P/E Ratio
−3.9x−5.5x−0.3x
PEG Ratio
−0.10−0.080.00
Price/Book
2.3x4.0x2.6x
Price / LTM Sales
3.9x4.2x3.0x
Upside (Analyst Target)
-197.6%55.4%
Fair Value Upside
Unlock−3.7%8.8%Unlock

Atomo Diagnostics Limited engages in the development and sale of medical devices worldwide. The company offers blood test devices, such as Pascal, Curie, Galileo, Elion, and Florey under the AtomoRapid brand. It also offers HIV Rapid self-Test device; and digital health solutions. Atomo Diagnostics Limited was incorporated in 2010 and is headquartered in Leichhardt, Australia.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
378.42M41.93%6.81M
Public Companies & Retail Investors
524.02M58.07%9.43M
Total
902.43M100.00%16.24M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Gz Family Holdings Pty Ltd9.96%89,895,6441,618
Dalraida Holdings Pty Limited7.22%65,120,0001,172

FAQ

What Is the Atomo (AT1) Stock Price Today?

The Atomo stock price today is 0.02 AUD.

What Stock Exchange Does Atomo Trade On?

Atomo is listed and trades on the Sydney Stock Exchange.

What Is the Stock Symbol for Atomo?

The stock symbol for Atomo is "AT1."

What Is the Atomo Market Cap?

As of today, Atomo market cap is 15.34M AUD.

What Is Atomo's Earnings Per Share (TTM)?

The Atomo EPS (TTM) is -0.01.

When Is the Next Atomo Earnings Date?

Atomo will release its next earnings report on Aug 31, 2026.

From a Technical Analysis Perspective, Is AT1 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Atomo Stock Split?

Atomo has split 0 times.

How Many Employees Does Atomo Have?

Atomo has 85 employees.

What is the current trading status of Atomo (AT1)?

As of Jul 24, 2026, Atomo (AT1) is trading at a price of 0.02 AUD, with a previous close of 0.02 AUD. The stock has fluctuated within a day range of 0.02 AUD to 0.02 AUD, while its 52-week range spans from 0.02 AUD to 0.05 AUD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.